First patent application granted for CRISPR-Cas9 gene editing in all environments
On May 25, 2012, Drs. Jennifer Doudna, Emanulle Charpentier, Martin Jinek of UC Berkeley and Krzystof Chylinski of the University of Vienna filed ‘first to file’ patent application for CRISPR-Cas9 gene editing in all environments, including bacteria, plant, animal and human cells.
It is difficult to overestimate the importance of the technique as it enables one not only to manipulate genomes of model organisms in scientific experiments, and modify characteristics of important crops and animals, but also has the potential of introducing revolutionary changes in medicine, especially in treatment of genetic diseases.
Tags:
Source: National Library of Medicine
Credit: Image: Original Life Science Cartoon: The Evolution of CRISPR illustrates its climb out of the primordial ocean on the backs of eukaryotic cells and its discovery, characterization and patenting by scientists like Francisco Mojica, Virginijus Šikšnys, and Emmanuelle Charpentier and Jennifer Doudna. Courtesy: Phil Ness and Mark Reeve.
